BIOMAT Database Logo BIOMAT Database Logo

[Usefulness of lithium in neutropenia associated with AIDS]. 1996

M Martinez Ruiz, and G Llobell Segui, and J I Peralba Vaño, and J R Toral Revuelta

UI MeSH Term Description Entries
D008297 Male Males
D009503 Neutropenia A decrease in the number of NEUTROPHILS found in the blood. Neutropenias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U
D016651 Lithium Carbonate A lithium salt, classified as a mood-stabilizing agent. Lithium ion alters the metabolism of BIOGENIC MONOAMINES in the CENTRAL NERVOUS SYSTEM, and affects multiple neurotransmission systems. CP-15,467-61,Dilithium Carbonate,Eskalith,Lithane,Lithium Bicarbonate,Lithobid,Lithonate,Lithotabs,Micalith,NSC-16895,Priadel,Quilinorm-retard,Bicarbonate, Lithium,CP 15,467 61,CP15,46761,Carbonate, Dilithium,Carbonate, Lithium,NSC 16895,NSC16895,Quilinorm retard,Quilinormretard

Related Publications

M Martinez Ruiz, and G Llobell Segui, and J I Peralba Vaño, and J R Toral Revuelta
Lack of effect of lithium carbonate on zidovudine-associated neutropenia in patients with AIDS.
September 1990, The Journal of infectious diseases,
M Martinez Ruiz, and G Llobell Segui, and J I Peralba Vaño, and J R Toral Revuelta
Lithium for zidovudine-induced neutropenia in AIDS.
August 1989, JAMA,
M Martinez Ruiz, and G Llobell Segui, and J I Peralba Vaño, and J R Toral Revuelta
Lithium for zidovudine-induced neutropenia in AIDS.
January 1988, JAMA,
M Martinez Ruiz, and G Llobell Segui, and J I Peralba Vaño, and J R Toral Revuelta
Absence of neutropenia in African patients with AIDS and associated pyomyositis.
November 1994, East African medical journal,
M Martinez Ruiz, and G Llobell Segui, and J I Peralba Vaño, and J R Toral Revuelta
Lithium carbonate therapy for zidovudine-associated neutropenia in patients with acquired immunodeficiency syndrome.
September 1989, The American journal of medicine,
M Martinez Ruiz, and G Llobell Segui, and J I Peralba Vaño, and J R Toral Revuelta
Lithium therapy of children with chronic neutropenia.
May 1981, The American journal of medicine,
M Martinez Ruiz, and G Llobell Segui, and J I Peralba Vaño, and J R Toral Revuelta
Prevention of antiblastic neutropenia with lithium carbonate.
April 1979, Lancet (London, England),
M Martinez Ruiz, and G Llobell Segui, and J I Peralba Vaño, and J R Toral Revuelta
[Filgrastim (rG-CSF) and neutropenia associated with AIDS, is MEDLINE lying?].
February 1993, Medicina clinica,
M Martinez Ruiz, and G Llobell Segui, and J I Peralba Vaño, and J R Toral Revuelta
Lithium therapy in congenital neutropenia.
January 1977, Lancet (London, England),
M Martinez Ruiz, and G Llobell Segui, and J I Peralba Vaño, and J R Toral Revuelta
Lithium therapy in childhood neutropenia.
January 1983, The Journal of pediatrics,
Copied contents to your clipboard!